Natural spring water gargle and direct RT-PCR for the diagnosis of COVID-19 (COVID-SPRING study).


Journal

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671

Informations de publication

Date de publication:
11 2021
Historique:
received: 11 03 2021
revised: 13 09 2021
accepted: 29 09 2021
pubmed: 8 10 2021
medline: 3 11 2021
entrez: 7 10 2021
Statut: ppublish

Résumé

Nasopharyngeal swab has long been considered the specimen of choice for the diagnosis of respiratory viral infections, including SARS-CoV-2 infection, but it suffers from several drawbacks: its discomfort limits screening acceptability, and it is vulnerable to shortages in both specialized materials and trained healthcare workers in the context of a pandemic. We prospectively compared natural spring water gargle to combined oro-nasopharyngeal swab (ONPS) for the diagnosis of coronavirus disease 2019 (COVID-19) in paired clinical specimens (1005 ONPS and 1005 gargles) collected from 987 unique early symptomatic as well as asymptomatic individuals from the community. Using a direct RT-PCR method with the Allplex™ 2019-nCoV Assay (Seegene), the clinical sensitivity of the gargle was 95.3% (95% confidence interval [CI], 90.2 - 98.3%), similar to the sensitivity of the ONPS (93.8%; 95% CI, 88.2 - 97.3%), despite significantly lower viral RNA concentration in gargles, as reflected by higher cycle threshold values. No single specimen type detected all COVID-19 cases. SARS-CoV-2 RNA was stable in gargles at room temperature for at least 7 days. The simplicity of this sampling method coupled with the accessibility of spring water are clear advantages in a pandemic situation where testing frequency, turnaround time and shortage of consumables and trained staff are critical elements.

Sections du résumé

BACKGROUND
Nasopharyngeal swab has long been considered the specimen of choice for the diagnosis of respiratory viral infections, including SARS-CoV-2 infection, but it suffers from several drawbacks: its discomfort limits screening acceptability, and it is vulnerable to shortages in both specialized materials and trained healthcare workers in the context of a pandemic.
METHODS
We prospectively compared natural spring water gargle to combined oro-nasopharyngeal swab (ONPS) for the diagnosis of coronavirus disease 2019 (COVID-19) in paired clinical specimens (1005 ONPS and 1005 gargles) collected from 987 unique early symptomatic as well as asymptomatic individuals from the community.
RESULTS
Using a direct RT-PCR method with the Allplex™ 2019-nCoV Assay (Seegene), the clinical sensitivity of the gargle was 95.3% (95% confidence interval [CI], 90.2 - 98.3%), similar to the sensitivity of the ONPS (93.8%; 95% CI, 88.2 - 97.3%), despite significantly lower viral RNA concentration in gargles, as reflected by higher cycle threshold values. No single specimen type detected all COVID-19 cases. SARS-CoV-2 RNA was stable in gargles at room temperature for at least 7 days.
CONCLUSION
The simplicity of this sampling method coupled with the accessibility of spring water are clear advantages in a pandemic situation where testing frequency, turnaround time and shortage of consumables and trained staff are critical elements.

Identifiants

pubmed: 34619381
pii: S1386-6532(21)00262-6
doi: 10.1016/j.jcv.2021.104995
pmc: PMC8487097
pii:
doi:

Substances chimiques

RNA, Viral 0
Water 059QF0KO0R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104995

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Références

Clin Infect Dis. 2021 May 4;72(9):e352-e356
pubmed: 32761244
Clin Infect Dis. 2021 Nov 2;73(9):e3127-e3129
pubmed: 33570097
J Clin Virol. 2020 Sep;130:104567
pubmed: 32750665
J Med Microbiol. 2021 Aug;70(8):
pubmed: 34369860
N Engl J Med. 2020 Nov 26;383(22):e120
pubmed: 32997903
Clin Infect Dis. 2020 Jun 16;:
pubmed: 32556191
Med (N Y). 2021 Mar 12;2(3):263-280.e6
pubmed: 33521748
J Clin Virol. 2020 Jul;128:104469
pubmed: 32474371
N Engl J Med. 2020 Sep 24;383(13):1283-1286
pubmed: 32857487
Virol J. 2020 Dec 18;17(1):196
pubmed: 33339539
Infect Control Hosp Epidemiol. 2021 Nov;42(11):1340-1344
pubmed: 33436122
Clin Infect Dis. 2021 Feb 1;72(3):403-410
pubmed: 33527126
JAMA Intern Med. 2021 Mar 1;181(3):353-360
pubmed: 33449069
Indian J Med Res. 2020 Jul & Aug;152(1 & 2):77-81
pubmed: 32820725
J Virol Methods. 2017 Oct;248:83-86
pubmed: 28633963
Viruses. 2020 Nov 17;12(11):
pubmed: 33212817
J Clin Virol. 2020 Jul;128:104423
pubmed: 32416598
J Clin Microbiol. 2021 Mar 19;59(4):
pubmed: 33514627

Auteurs

Jeannot Dumaresq (J)

Département de Microbiologie et d'Infectiologie, CISSS de Chaudière-Appalaches, Lévis, Québec, Canada; Département de microbiologie-infectiologie et d'immunologie, Faculté de Médecine, Université Laval, Québec, Québec, Canada. Electronic address: jeannot.dumaresq.med@ssss.gouv.qc.ca.

François Coutlée (F)

Service de Biologie moléculaire, Département des laboratoires de biologie médicale et Service d'infectiologie, Département de Médecine, Centre hospitalier de l'Université de Montréal, Canada; Département de Microbiologie, infectiologie et Immunologie, Université de Montréal, Montréal, H2 × 3E4, Canada.

Philippe J Dufresne (PJ)

Laboratoire de santé publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Qc, Canada.

Jean Longtin (J)

Département de microbiologie-infectiologie et d'immunologie, Faculté de Médecine, Université Laval, Québec, Québec, Canada; Département de microbiologie et d'infectiologie du centre hospitalier universitaire (CHU) de Québec, Québec, Canada.

Judith Fafard (J)

Département de Microbiologie, infectiologie et Immunologie, Université de Montréal, Montréal, H2 × 3E4, Canada; Laboratoire de santé publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Qc, Canada.

Julie Bestman-Smith (J)

Département de microbiologie-infectiologie et d'immunologie, Faculté de Médecine, Université Laval, Québec, Québec, Canada; Département de microbiologie et d'infectiologie du centre hospitalier universitaire (CHU) de Québec, Québec, Canada.

Marco Bergevin (M)

Département de biologie médicale Hôpital Cité-de-la-Santé, Laval, QC, H7M 3L9, Canada.

Emilie Vallières (E)

Département de Microbiologie, infectiologie et Immunologie, Université de Montréal, Montréal, H2 × 3E4, Canada; Service de microbiologie, Département clinique de médecine de laboratoire et Service de maladies infectieuses, Département de pédiatrie, CHU Sainte-Justine, Montréal, Qc, Canada.

Marc Desforges (M)

Service de microbiologie, Département clinique de médecine de laboratoire et Service de maladies infectieuses, Département de pédiatrie, CHU Sainte-Justine, Montréal, Qc, Canada.

Annie-Claude Labbé (AC)

Département de Microbiologie, infectiologie et Immunologie, Université de Montréal, Montréal, H2 × 3E4, Canada; Service de maladies infectieuses, Département de Médecine, CIUSSS de l'Est-de-l'Île-de-Montreal, Montréal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH